These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9923454)

  • 1. Synergy of growth factors during mobilization of peripheral blood precursor cells with recombinant human Flt3-ligand and granulocyte colony-stimulating factor in rabbits.
    Pless M; Wodnar-Filipowicz A; John L; Baldomero H; Lyman SD; Nissen C; Gratwohl A
    Exp Hematol; 1999 Jan; 27(1):155-61. PubMed ID: 9923454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.
    Brasel K; McKenna HJ; Charrier K; Morrissey PJ; Williams DE; Lyman SD
    Blood; 1997 Nov; 90(9):3781-8. PubMed ID: 9345066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice.
    Sudo Y; Shimazaki C; Ashihara E; Kikuta T; Hirai H; Sumikuma T; Yamagata N; Goto H; Inaba T; Fujita N; Nakagawa M
    Blood; 1997 May; 89(9):3186-91. PubMed ID: 9129021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of Flt3/Flk2 ligand on mobilization of hematopoietic progenitors in primates and potent synergistic enhancement with granulocyte colony-stimulating factor.
    Papayannopoulou T; Nakamoto B; Andrews RG; Lyman SD; Lee MY
    Blood; 1997 Jul; 90(2):620-9. PubMed ID: 9226162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L; Scambia G; Bonanno G; Coscarella A; De Santis R; Mele A; Battaglia A; Fattorossi A; Romeo V; Menichella G; Mancuso S; Leone G
    Exp Hematol; 1999 Mar; 27(3):416-24. PubMed ID: 10089903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates.
    MacVittie TJ; Farese AM; Davis TA; Lind LB; McKearn JP
    Exp Hematol; 1999 Oct; 27(10):1557-68. PubMed ID: 10517498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flt-3 ligand synergizes with granulocyte colony-stimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential.
    Molineux G; McCrea C; Yan XQ; Kerzic P; McNiece I
    Blood; 1997 Jun; 89(11):3998-4004. PubMed ID: 9166838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of FLT3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: kinetics and repopulating potential.
    Neipp M; Zorina T; Domenick MA; Exner BG; Ildstad ST
    Blood; 1998 Nov; 92(9):3177-88. PubMed ID: 9787154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs.
    de Revel T; Appelbaum FR; Storb R; Schuening F; Nash R; Deeg J; McNiece I; Andrews R; Graham T
    Blood; 1994 Jun; 83(12):3795-9. PubMed ID: 7515722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
    Cairo MS; Plunkett JM; Schendel P; van de Ven C
    Exp Hematol; 1994 Oct; 22(11):1118-23. PubMed ID: 7523164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human FLT3 ligand acts on myeloid as well as multipotential progenitors derived from purified CD34+ blood progenitors expressing different levels of c-kit protein.
    Sonoda Y; Kimura T; Sakabe H; Tanimukai S; Ohmizono Y; Nakagawa S; Yokota S; Lyman SD; Abe T
    Eur J Haematol; 1997 Apr; 58(4):257-64. PubMed ID: 9186537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
    Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of FL on ex vivo expansion of hematopoietic cells from cord blood in long-term liquid cultures.
    Zhang X; Cai H; Zhao J; Tan W; Yu J
    Chin J Biotechnol; 1999; 15(3):189-94. PubMed ID: 10935167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-CSF versus GM-CSF for stimulation of peripheral blood progenitor cells (PBPC) and leukocytes in healthy volunteers: comparison of efficacy and tolerability.
    Fischmeister G; Kurz M; Haas OA; Micksche M; Buchinger P; Printz D; Ressmann G; Stroebel T; Peters C; Fritsch G; Gadner H
    Ann Hematol; 1999 Mar; 78(3):117-23. PubMed ID: 10211753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FLT3/FLK2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units.
    Hudak S; Hunte B; Culpepper J; Menon S; Hannum C; Thompson-Snipes L; Rennick D
    Blood; 1995 May; 85(10):2747-55. PubMed ID: 7537980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.